STATE OF THE ART PAPER
Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
 
More details
Hide details
Submission date: 2015-08-27
Final revision date: 2015-11-18
Acceptance date: 2015-11-18
Online publication date: 2016-06-30
Publication date: 2016-12-22
 
Arch Med Sci 2017;13(1):210–214
 
KEYWORDS
TOPICS
ABSTRACT
High-density lipoproteins (HDL) have received considerable interest as a target for the development of novel anti-atherosclerotic agents beyond conventional approaches to lipid lowering. While a number of approaches have focused on modifying remodeling and expression pathways implicated in the regulation of HDL levels, an additional approach involves simply infusions of delipidated HDL. Several groups have advanced HDL infusions to clinical development with intriguing signs suggesting potentially favorable impacts at the level of the artery wall. The findings of early studies of infusional HDL therapies will be reviewed.
eISSN:1896-9151
ISSN:1734-1922